StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
636
This month
13
This week
4
This year
60
Today
2
Yesterday
2
Publishing Date
2024 - 03 - 25
3
2024 - 02 - 06
3
2024 - 01 - 08
3
2023 - 11 - 06
3
2023 - 10 - 16
3
2023 - 05 - 09
4
2023 - 03 - 13
3
2023 - 03 - 02
3
2023 - 02 - 07
3
2022 - 11 - 04
4
2022 - 11 - 02
3
2022 - 09 - 05
3
2022 - 06 - 20
3
2022 - 05 - 11
4
2022 - 05 - 03
6
2022 - 05 - 02
3
2022 - 04 - 05
3
2022 - 03 - 28
4
2022 - 03 - 24
4
2022 - 02 - 21
3
2022 - 01 - 04
3
2021 - 11 - 12
3
2021 - 11 - 09
4
2021 - 11 - 05
3
2021 - 09 - 15
2
2021 - 08 - 31
2
2021 - 08 - 30
3
2021 - 08 - 25
2
2021 - 08 - 16
2
2021 - 08 - 11
2
2021 - 08 - 09
2
2021 - 08 - 06
3
2021 - 08 - 04
2
2021 - 07 - 29
3
2021 - 07 - 22
2
2021 - 07 - 12
3
2021 - 07 - 09
2
2021 - 06 - 26
2
2021 - 06 - 22
2
2021 - 06 - 21
2
2021 - 06 - 16
3
2021 - 06 - 14
2
2021 - 06 - 09
2
2021 - 06 - 07
2
2021 - 05 - 28
3
2021 - 05 - 27
3
2021 - 05 - 25
3
2021 - 05 - 11
3
2021 - 05 - 07
3
2021 - 05 - 04
2
2021 - 04 - 21
2
2021 - 04 - 19
2
2021 - 04 - 13
2
2021 - 04 - 08
2
2021 - 03 - 29
2
2021 - 03 - 25
3
2021 - 03 - 18
4
2021 - 03 - 16
2
2021 - 03 - 15
2
2020 - 12 - 07
2
Sector
Commercial services
5
Communications
2
Consumer durables
2
Consumer non-durables
3
Consumer services
1
Distribution services
1
Electronic technology
5
Energy minerals
1
Finance
14
Finance and insurance
3
Health care and social assistance
1
Health services
4
Health technology
636
Manufacturing
17
N/a
7
Process industries
1
Producer manufacturing
1
Professional, scientific, and technical services
4
Retail trade
2
Technology services
4
Tags
Acquire
7
Agreement
5
Application
6
Approval
7
Biotech
7
Biotechnology
5
Bleeding
7
Blood
5
Cancer
6
Cardiovascular
5
Collaboration
8
Companies
6
Conference
20
Device
5
Diabetes
34
Disease
18
Drug
18
Earnings
8
Europe
10
Events
22
Expansion
7
Expected
10
Fda
11
Financial
7
Financial results
7
Genetown
7
Global
45
Growing
5
Growth
33
Hormone
7
Insulin
32
Iot
6
Kidney
5
Liver
11
Market
79
Money
8
N/a
520
Obesity
16
People
11
Pharma
81
Pharmaceutical
12
Phase 2
7
Phase 3
6
Program
10
Reach
10
Report
39
Repurchase
97
Research
34
Results
20
S
42
Sales
13
Sanofi
7
Study
6
Technology
10
Therapeutics
27
Therapy
11
Treatment
34
Trial
32
Trials
9
Update
12
Entities
3m company
938
Abb ltd
1433
Abbott laboratories
1797
Abbvie inc.
1030
Accenture plc
602
Alphabet inc.
1304
Amgen inc.
744
Apple inc.
1198
Arcelormittal
593
Arrival
4321
Astrazeneca plc
668
Bank of montreal
545
Becton, dickinson and company
796
Bnp paribas
1769
Boston scientific corporation
577
Bristol-myers squibb company
662
Broadcom inc.
597
Cisco systems, inc.
900
Cummins inc.
542
Danaher corporation
786
Dell technologies inc.
579
Dow inc.
556
Eli lilly and company
1712
Ericsson
1617
Extreme networks, inc.
581
First bank
602
Ford motor company
643
Gartner, inc.
595
General electric company
919
Glaxosmithkline plc
888
Honeywell international inc.
1793
Hubspot, inc.
1400
Intel corporation
956
International business machines corporation
657
Johnson & johnson
4608
Kering
1133
Koninklijke philips n.v.
963
Lithium corp
973
Live nation entertainment, inc.
717
Lockheed martin corporation
576
Medtronic plc
1286
Microsoft corporation
1205
Morgan stanley
4299
Nokia corp
993
Nokia corporation
917
Northrop grumman corporation
590
Novartis ag
1245
Novo nordisk a/s
636
Oracle corporation
1161
Orange
7230
Panasonic corp
651
Pfizer, inc.
693
Sanofi
4563
Sap se
1481
Snowflake inc.
796
Stellantis n.v
536
Teva pharmaceutical industries ltd
633
Thermo fisher scientific inc
1630
Verizon communications inc.
1223
X financial
678
Symbols
ABBV
14
ABT
20
ALNY
25
ALPMF
3
ALPMY
3
ALT
2
AMGN
17
AMZN
2
AZN
30
AZNCF
20
BAX
8
BDX
12
BHC
2
BIIB
7
BLK
5
BMY
7
BNPQF
3
BNPQY
3
BSX
3
CMXHF
3
CRL
2
CSLLY
3
CTLT
2
DNLI
2
DXCM
3
EIGR
2
ENDP
5
ENDPQ
4
ENTX
2
GALT
3
GILD
10
GLAXF
21
GMAB
4
GSK
27
ICLR
5
IONS
3
IPHA
71
IPHYF
44
JNJ
44
LLY
83
LPCN
3
MDGL
3
MDT
14
NVO
636
NVS
28
NVSEF
27
PFE
11
PODD
11
REGN
4
RVP
4
SNY
139
SNYNF
100
TAK
15
TEVJF
15
TMO
4
TRUMF
9
TRUMY
9
VRTX
3
VTRS
7
ZEAL
9
Exchanges
Amex
5
Nasdaq
251
Nyse
636
Crawled Date
2024 - 03 - 25
3
2024 - 02 - 06
3
2024 - 01 - 08
3
2023 - 11 - 06
3
2023 - 10 - 16
3
2023 - 09 - 13
3
2023 - 05 - 09
4
2023 - 03 - 13
3
2023 - 03 - 02
3
2023 - 02 - 23
3
2023 - 02 - 07
3
2022 - 11 - 04
4
2022 - 11 - 02
3
2022 - 09 - 05
3
2022 - 06 - 20
3
2022 - 05 - 11
4
2022 - 05 - 03
6
2022 - 05 - 02
3
2022 - 04 - 05
3
2022 - 03 - 28
4
2022 - 03 - 24
4
2022 - 02 - 21
3
2022 - 01 - 04
3
2021 - 11 - 12
3
2021 - 11 - 09
4
2021 - 11 - 05
3
2021 - 08 - 30
3
2021 - 08 - 25
2
2021 - 08 - 16
2
2021 - 08 - 11
2
2021 - 08 - 09
2
2021 - 08 - 06
3
2021 - 08 - 04
2
2021 - 07 - 29
3
2021 - 07 - 22
2
2021 - 07 - 12
3
2021 - 07 - 09
2
2021 - 06 - 27
2
2021 - 06 - 22
2
2021 - 06 - 21
2
2021 - 06 - 16
3
2021 - 06 - 14
2
2021 - 06 - 09
2
2021 - 06 - 07
2
2021 - 05 - 28
3
2021 - 05 - 27
3
2021 - 05 - 25
3
2021 - 05 - 11
3
2021 - 05 - 07
3
2021 - 05 - 04
2
2021 - 04 - 21
2
2021 - 04 - 19
2
2021 - 04 - 13
2
2021 - 04 - 08
2
2021 - 03 - 29
2
2021 - 03 - 25
3
2021 - 03 - 18
4
2021 - 03 - 16
2
2021 - 03 - 15
2
2020 - 12 - 07
2
Crawled Time
00:00
4
00:20
3
01:00
7
02:00
6
03:00
1
04:00
3
04:20
5
05:00
5
06:00
33
07:00
36
07:04
1
08:00
31
09:00
15
10:00
29
11:00
35
11:33
1
12:00
65
12:15
9
12:20
16
12:30
10
13:00
40
13:15
7
13:20
9
13:30
9
14:00
38
14:05
1
14:15
3
14:20
6
14:30
5
15:00
39
15:01
1
15:15
2
15:20
8
15:30
8
16:00
24
16:20
2
17:00
23
17:01
1
18:00
20
19:00
14
20:00
16
20:20
1
21:00
19
21:06
1
22:00
16
23:00
8
Source
www.aspenpharma.com
1
www.biospace.com
113
www.globenewswire.com
345
www.prnewswire.com
177
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Novo nordisk a::S
save search
Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published:
2023-12-22
(Crawled : 17:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-1.89%
|
O:
3.66%
H:
0.0%
C:
-0.12%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
3.72%
|
O:
3.33%
H:
0.0%
C:
-2.93%
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
21.92%
|
O:
-0.31%
H:
0.39%
C:
-0.44%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-3.5%
|
O:
1.09%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
31.51%
|
O:
0.18%
H:
0.5%
C:
-0.46%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-4.68%
|
O:
-0.78%
H:
5.15%
C:
2.81%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
9.97%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-2.64%
|
O:
1.03%
H:
0.0%
C:
0.0%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
7.68%
|
O:
0.52%
H:
0.58%
C:
0.05%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-15.01%
|
O:
0.34%
H:
1.02%
C:
0.59%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-20.43%
|
O:
0.57%
H:
1.36%
C:
1.04%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
7.39%
|
O:
1.06%
H:
0.18%
C:
-1.06%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-2.26%
|
O:
0.24%
H:
2.03%
C:
1.49%
patent
report
global
market
Novo Nordisk A/S - share repurchase programme
Published:
2023-12-22
(Crawled : 12:00)
- globenewswire.com
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
21.92%
|
O:
-0.31%
H:
0.39%
C:
-0.44%
repurchase
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published:
2023-12-19
(Crawled : 08:00)
- biospace.com/
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
27.46%
|
O:
0.91%
H:
0.72%
C:
0.11%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-2.07%
|
O:
0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.47
4.22%
4.05%
690
|
Health Technology
|
0.41%
|
O:
13.88%
H:
0.0%
C:
-3.58%
pharma
natural
cell
sanofi
Novo Nordisk A/S - share repurchase programme
Published:
2023-12-18
(Crawled : 13:30)
- globenewswire.com
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
29.93%
|
O:
2.49%
H:
0.28%
C:
-0.54%
repurchase
Incretin-based Drugs Market to Reach $73.9 billion, globally, by 2032 at 7.9% CAGR: Allied Market Research
Published:
2023-12-15
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
2.15%
|
O:
-3.0%
H:
2.15%
C:
2.15%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-2.04%
|
O:
0.0%
H:
0.0%
C:
0.0%
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
28.73%
|
O:
-0.48%
H:
0.0%
C:
-0.44%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-0.53%
|
O:
-1.31%
H:
0.56%
C:
-0.17%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
26.71%
|
O:
-4.44%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-1.77%
|
O:
-0.93%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
7.31%
|
O:
-2.23%
H:
0.28%
C:
-0.11%
reach
research
market
Liberty All-Star Equity Fund November 2023 Monthly Update
Published:
2023-12-13
(Crawled : 18:00)
- prnewswire.com
SNEJF
|
News
|
$81.888
2.78%
42K
|
Consumer Durables
|
-9.7%
|
O:
-0.26%
H:
3.39%
C:
3.39%
SKX
4
|
$59.15
-0.82%
0.0%
2.1M
|
Consumer Non-Durables
|
-3.84%
|
O:
1.19%
H:
1.61%
C:
0.58%
NOW
|
$746.29
0.72%
-4.85%
1.6M
|
Technology Services
|
4.28%
|
O:
-0.79%
H:
0.3%
C:
-4.17%
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
27.56%
|
O:
-0.38%
H:
0.21%
C:
-0.53%
IQV
|
$240.84
0.93%
0.0%
1.5M
|
Health Services
|
6.59%
|
O:
0.35%
H:
3.61%
C:
1.68%
SWKS
4
|
$101.14
1.85%
1.82%
1.9M
|
Electronic Technology
|
-7.2%
|
O:
0.94%
H:
3.45%
C:
3.11%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
3.47%
|
O:
-0.26%
H:
0.56%
C:
0.25%
PYPL
4
|
$64.84
0.64%
0.63%
7.8M
|
Technology Services
|
5.04%
|
O:
1.96%
H:
1.89%
C:
-1.7%
ADSK
|
$214.97
-1.36%
-1.38%
2.6M
|
Technology Services
|
-8.48%
|
O:
0.19%
H:
3.09%
C:
2.32%
AMZN
S
|
$176.57
-1.65%
-3.18%
32M
|
Retail Trade
|
18.64%
|
O:
0.73%
H:
0.41%
C:
-1.67%
update
liberty
Novo Nordisk A/S - share repurchase programme
Published:
2023-12-11
(Crawled : 13:30)
- globenewswire.com
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
30.55%
|
O:
-0.22%
H:
0.68%
C:
0.23%
repurchase
Hoba Therapeutics raises EUR 23 million in a Series A to advance new drug candidate against chronic neuropathic pain
Published:
2023-12-11
(Crawled : 07:00)
- prnewswire.com
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
30.55%
|
O:
-0.22%
H:
0.68%
C:
0.23%
drug
candidate
series
therapeutics
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published:
2023-12-08
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-23.05%
|
O:
-2.79%
H:
0.62%
C:
0.62%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
3.78%
|
O:
2.06%
H:
0.82%
C:
0.82%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-0.9%
|
O:
-1.29%
H:
0.4%
C:
0.4%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-22.76%
|
O:
-2.2%
H:
0.0%
C:
-0.27%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-6.04%
|
O:
-0.64%
H:
0.5%
C:
0.5%
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
30.32%
|
O:
-0.42%
H:
0.67%
C:
0.25%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
2.52%
|
O:
0.19%
H:
0.35%
C:
0.2%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-5.02%
|
O:
-0.18%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
28.23%
|
O:
0.43%
H:
0.0%
C:
0.0%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-2.59%
|
O:
0.2%
H:
0.55%
C:
0.1%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
13.54%
|
O:
0.3%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
3.77%
|
O:
1.07%
H:
0.0%
C:
0.0%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-14.06%
|
O:
0.08%
H:
1.45%
C:
1.17%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
0.63%
|
O:
-0.05%
H:
0.3%
C:
-0.76%
reach
market
Novo Nordisk A/S - share repurchase programme
Published:
2023-12-04
(Crawled : 12:30)
- globenewswire.com
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
25.66%
|
O:
0.17%
H:
0.57%
C:
0.35%
repurchase
energyRe Announces $1.2 Billion Capital Raise to Accelerate U.S. Clean Energy Transition
Published:
2023-12-04
(Crawled : 12:30)
- prnewswire.com
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
25.66%
|
O:
0.17%
H:
0.57%
C:
0.35%
energy
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
Published:
2023-11-28
(Crawled : 12:30)
- globenewswire.com
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
21.46%
|
O:
-1.93%
H:
0.37%
C:
-0.43%
PDSB
|
$3.26
1.88%
1.84%
450K
|
Health Technology
|
-44.92%
|
O:
-3.39%
H:
0.7%
C:
-6.49%
PODD
|
$167.215
-0.03%
-0.03%
650K
|
Health Technology
|
-10.91%
|
O:
-0.87%
H:
1.19%
C:
-0.21%
biotech
financial
Novo Nordisk A/S - share repurchase programme
Published:
2023-11-27
(Crawled : 14:00)
- globenewswire.com
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
19.64%
|
O:
-0.54%
H:
0.53%
C:
-0.96%
repurchase
Novo Nordisk invests more than 16 billion Danish kroner in expansion of production facilities in Chartres, France
Published:
2023-11-23
(Crawled : 16:00)
- globenewswire.com
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
Email alert
Add to watchlist
expansion
Novo Nordisk A/S - share repurchase programme
Published:
2023-11-20
(Crawled : 15:00)
- globenewswire.com
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
24.43%
|
O:
0.11%
H:
2.21%
C:
2.06%
repurchase
Type 1 Diabetes Market to Accelerate Substantially During the Study Period (2019-2032), Predicts DelveInsight | Leading Companies Developing Therapies - Eli Lilly, Vertex, Bayer, Novo Nordisk, Rise, Tolerion, BioKier, Dompé Farmaceutici
Published:
2023-11-15
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
6.41%
|
O:
3.37%
H:
1.29%
C:
1.29%
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
30.83%
|
O:
2.62%
H:
0.67%
C:
0.58%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
23.21%
|
O:
-3.12%
H:
0.61%
C:
-0.46%
VRTX
|
$400.66
-1.05%
-1.06%
810K
|
Health Technology
|
14.72%
|
O:
0.4%
H:
0.38%
C:
-2.2%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
4.6%
|
O:
1.54%
H:
0.0%
C:
0.0%
companies
diabetes
study
market
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published:
2023-11-14
(Crawled : 11:00)
- globenewswire.com
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
25.18%
|
O:
-1.07%
H:
0.09%
C:
-0.5%
Novo Nordisk A/S - share repurchase programme
Published:
2023-11-13
(Crawled : 20:00)
- globenewswire.com
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
25.18%
|
O:
-1.07%
H:
0.09%
C:
-0.5%
repurchase
Trading in Novo Nordisk shares by board members, executives and associated persons
Published:
2023-11-13
(Crawled : 12:00)
- globenewswire.com
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
24.68%
|
O:
-1.72%
H:
2.53%
C:
1.34%
Novo Nordisk A/S: Semaglutide 2.4 mg (Wegovy®) cardiovascular outcomes data presented at American Heart Association Scientific Sessions and simultaneously published in New England Journal of Medicine
Published:
2023-11-11
(Crawled : 16:20)
- globenewswire.com
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
Email alert
Add to watchlist
wegovy
association
sessions
heart
cardiovascular
← Previous
1
2
3
4
5
6
7
8
9
…
31
32
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.